Maintenance fees coming due
122 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Nov 16, 2026. Unpaid by May 17, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,648,176 | Medicine Container, Method of Assembling the Container, and Method of Dispensing the Medicine from the Container In force Fee due Nov 16, 2026 Lapses if unpaid May 17, 2027 · High confidence | AbbVie Inc. | In force | Nov 16, 2026 | May 17, 2027 | High confidence | |
| US 9,034,832 | Solid Compositions In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · Medium confidence | AbbVie Inc. | In force | Nov 19, 2026 | May 19, 2027 | Medium confidence | |
| US 9,035,047 | 7-Substituted Indole MCL-1 Inhibitors In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | AbbVie Inc. | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 10,300,200 | Automatic Injection Device with Near-Field Communication In force Fee due Nov 28, 2026 Lapses if unpaid May 28, 2027 · High confidence | AbbVie Inc. | In force | Nov 28, 2026 | May 28, 2027 | High confidence | |
| US 9,045,551 | ANTI-DLL4/VEGF Dual Variable Domain Immunoglobulin and Uses Thereof In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | AbbVie Inc. | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 9,046,513 | Dual Variable Domain Immunoglobulins and Uses Thereof In force Fee due Dec 2, 2026 Lapses if unpaid Jun 2, 2027 · High confidence | AbbVie Inc. | In force | Dec 2, 2026 | Jun 2, 2027 | High confidence | |
| US 10,308,610 | Novel Inhibitor Compounds of Phosphodiesterase Type 10A In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · Medium confidence | AbbVie Inc. | In force | Dec 4, 2026 | Jun 4, 2027 | Medium confidence | |
| US 10,308,713 | ANTI-CS1 Antibodies and Antibody Drug Conjugates In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | AbbVie Biotherapeutics Inc. | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 9,050,346 | Bromodomain Inhibitors In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · High confidence | AbbVie Inc. | In force | Dec 9, 2026 | Jun 9, 2027 | High confidence | |
| US 9,051,327 | Pyridazino[4,5-d]pyrimidin-5(6h)-one Inhibitors of Kinases In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · High confidence | AbbVie Inc. | In force | Dec 9, 2026 | Jun 9, 2027 | High confidence | |
| 112 more maintenance fees coming due in the 12 months from Nov 15, 2026 · Pro | |||||||
10 of 122 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.